Skip to main content
Clinical Trials/NCT01693874
NCT01693874
Completed
Phase 1

Mindfulness-based Stress Reduction and Cognitive Function in Stress and Aging

Washington University School of Medicine2 sites in 1 country103 target enrollmentOctober 2011

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Anxiety Disorders
Sponsor
Washington University School of Medicine
Enrollment
103
Locations
2
Primary Endpoint
cognitive functioning
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

The investigators are developing and then testing whether Mindfulness-Based Stress Reduction, a group-based instruction for increasing mindfulness, reduces anxiety and depressive symptoms and improves cognitive functioning in older adults.

Registry
clinicaltrials.gov
Start Date
October 2011
End Date
June 2014
Last Updated
11 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Eric Lenze

Professor of Psychiatry

Washington University School of Medicine

Eligibility Criteria

Inclusion Criteria

  • current depressive and/or anxiety symptoms
  • current depressive and/or anxiety disorder
  • able to participate in behavioral study

Exclusion Criteria

  • unable to participate in study

Outcomes

Primary Outcomes

cognitive functioning

Time Frame: approximately 2 months of study intervention

neuropsychological battery examining memory, executive functioning, and attention

Secondary Outcomes

  • mind-wandering(2 months of intervention)
  • mindfulness(2 months of intervention)
  • anxiety and depressive symptoms(2 months of intervention)

Study Sites (2)

Loading locations...

Similar Trials